TIMELY-PrdiktoR Study on Cardiac Rehabilitation Outcomes in Adults with Coronary Artery Disease
Led by Dr. Boris Schmitz · Updated on 2026-03-30
1200
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying cardiac rehabilitation CR for patients with coronary artery disease CAD who have experienced events like heart attacks or undergone procedures such as angioplasty or bypass surgery. The goal is to understand how CR helps manage symptoms, improve long-term health, and reduce future heart and brain blood vessel problems. This study focuses on collecting detailed data to explore how various biological, psychological, and social factors affect recovery and success of CR, using advanced data analysis including artificial intelligence.
Participants will undergo phase II CR, which is a structured program addressing heart disease and related conditions like high blood pressure, diabetes, and obesity. Data collection includes controlled center-based CR activities and remote monitoring of physical activity, blood pressure, pulse wave analysis, and long-term heart rhythm monitoring for six months after discharge. Follow-ups are scheduled at 6 and 12 months, and major heart and brain event data will be collected for up to 10 years.
Throughout the study, participants will have multiple assessments measuring fitness, mortality risk, physical activity, heart rate, sleep, stress, blood pressure, body composition, muscle function, mental health, quality of life, and social and psychological factors at various times from the start through 48 weeks. The study aims to track adherence to healthy lifestyle changes and acceptance of eHealth tools. This long-term monitoring helps researchers identify factors that predict successful rehabilitation and better long-term outcomes.
CONDITIONS
Brief Title
TIMELY-PrädiktoR Prospective Study
Research Team
B
Boris Schmitz, PhD
F
Frank C. Mooren, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Diagnosed with coronary artery disease after myocardial infarction (STEMI/NSTEMI), angioplasty, PCI, or coronary artery bypass surgery
Currently participating in phase II cardiac rehabilitation
You will not qualify if you...
Unable to provide informed consent
Conditions preventing participation in cardiac rehabilitation, including unstable coronary or cerebrovascular conditions
Acute infections
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Monitoring
Duration - 48 weeks
Participants with coronary artery disease who are undergoing phase II cardiac rehabilitation are observed over time to assess changes in cardiorespiratory fitness, risk of mortality, physical activity, and various health and psychological measures.
Visits at baseline, week 3, week 24, and week 48
Long-term Monitoring
Duration - Up to 432 weeks
Participants are followed up for major adverse cardiac and cerebrovascular events over an extended period to monitor long-term outcomes.
Periodic assessments from baseline to week 432
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Comparing 24-Month Versus 12-Month Dual Antiplatelet Therapy After Drug-Eluting Stent Placement in Patients With High Lipoproteina Levels
Evaluation of a 10-Minute Cardiovascular Magnetic Resonance Protocol for Diagnosing Cardiac Diseases Including Coronary Artery Disease and Cardiomyopathies
Study of Implantable Cardioverter Defibrillator Benefits in Adults with Coronary Artery Disease and Ventricular Fibrillation After Complete Revascularization
Randomized Double-Blind Study Evaluating Intravenous YN001 Versus Placebo in Adults With Coronary Atherosclerosis Receiving Cardiovascular Risk Therapy
Validating the ABCD-GENE Score to Identify Stable Coronary Artery Disease Patients Undergoing Elective PCI at Risk of Heart Injury During Procedure
Real-World Registry of Quantitative Flow Ratio-Guided Coronary Revascularization and Quality Evaluation Across Multiple Centers in China
Evaluating Coronary CT Angiography to Guide Calcium Modification Compared to Intravascular Ultrasound in Treating Calcified Coronary Artery Disease A Multicenter Randomized Trial
Study on Ultrasound Screening and Combined Treatments for Patients With Coronary and Head and Neck Artery Narrowing
Study of Yiyang Huoluo Decoction Combined with Western Medicine to Treat Coronary Heart Disease and Atherosclerosis in Older Adults
Evaluating Pre-Procedural Intracoronary Nicorandil to Prevent Reduced TIMI Flow in Patients Undergoing Percutaneous Coronary Intervention for Coronary Artery Disease
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Living Lab Data of Patient Needs and Expectations for eHealth-Based Cardiac Rehabilitation in Germany and Spain From the TIMELY Study: Cross-Sectional Analysis.
Boris Schmitz, Svenja Wirtz, Manuela Sestayo-Fernández...